Hologic, Inc. $HOLX Shares Bought by Gotham Asset Management LLC

Gotham Asset Management LLC raised its position in Hologic, Inc. (NASDAQ:HOLX) by 74.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 639,921 shares of the medical equipment provider’s stock after purchasing an additional 272,477 shares during the quarter. Gotham Asset Management LLC’s holdings in Hologic were worth $43,188,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HOLX. The Manufacturers Life Insurance Company increased its position in Hologic by 294.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,022,455 shares of the medical equipment provider’s stock worth $718,223,000 after purchasing an additional 8,227,318 shares in the last quarter. Invesco Ltd. lifted its position in Hologic by 72.5% during the second quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock valued at $543,486,000 after buying an additional 3,505,828 shares in the last quarter. Geode Capital Management LLC grew its stake in Hologic by 1.7% during the second quarter. Geode Capital Management LLC now owns 5,828,325 shares of the medical equipment provider’s stock worth $378,209,000 after buying an additional 97,142 shares during the period. Black Creek Investment Management Inc. grew its stake in Hologic by 26.1% during the second quarter. Black Creek Investment Management Inc. now owns 4,027,829 shares of the medical equipment provider’s stock worth $262,453,000 after buying an additional 832,444 shares during the period. Finally, Bank of America Corp DE increased its position in shares of Hologic by 2.2% in the second quarter. Bank of America Corp DE now owns 3,090,306 shares of the medical equipment provider’s stock worth $201,364,000 after acquiring an additional 66,453 shares in the last quarter. 94.73% of the stock is owned by institutional investors and hedge funds.

Hologic Trading Down 0.1%

NASDAQ HOLX opened at $75.12 on Monday. The company’s fifty day simple moving average is $75.13 and its 200-day simple moving average is $72.72. Hologic, Inc. has a 52 week low of $51.90 and a 52 week high of $75.75. The company has a current ratio of 4.04, a quick ratio of 3.32 and a debt-to-equity ratio of 0.48. The stock has a market cap of $16.77 billion, a P/E ratio of 31.30, a PEG ratio of 2.24 and a beta of 0.73.

Hologic (NASDAQ:HOLX) last announced its earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.05). The firm had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.07 billion. Hologic had a net margin of 13.18% and a return on equity of 19.58%. Hologic’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.87 earnings per share. Equities research analysts predict that Hologic, Inc. will post 4.28 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HOLX shares. BNP Paribas Exane downgraded shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 target price on the stock. in a research note on Friday, November 21st. Evercore cut shares of Hologic from an “outperform” rating to an “in-line” rating and decreased their price target for the stock from $79.00 to $78.00 in a research report on Monday, January 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Hologic in a research report on Wednesday, January 28th. Finally, Argus cut Hologic from a “buy” rating to a “hold” rating in a research note on Monday, January 12th. Two investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat, Hologic currently has a consensus rating of “Hold” and a consensus target price of $78.42.

Hologic Company Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.